Cefoxitin

Chemical formula: C₁₆H₁₇N₃O₇S₂  Molecular mass: 427.452 g/mol  PubChem compound: 441199

Therapeutic indications

Cefoxitin is indicated for:

Complicated urinary tract infections

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Urinary tract infectious disease and additionally at least one of
Cefoxitin susceptible species
Cefoxitin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Intra-abdominal infections

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Infectious disease of abdomen and additionally at least one of
Cefoxitin susceptible species
Cefoxitin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Female genital tract infections

Population group: women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Female genital tract infection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Cefoxitin is contraindicated in the following cases:

Allergy to cephalosporin antibacterial, history of severe hypersensitivity to penicillins, monobactams or carbapenems

at least one of
Cephalosporin allergy
Allergy to penicillin
Monobactam allergy
Carbapenem allergy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.